Investeringsoversigt

8477 investments

Titel Sort descending	Periode	Program
Globalisering af infrastruktur til innovativt mediehåndteringssystem	2016 - 2017	Innobooster
Globalisering af infrastruktur til innovativt mediehåndteringssystem Period 2016 - 2017 Region Region Syddanmark Program Innobooster Area Ikke defineret Investment Percentage 16.19 Invested 226.686 Budget 1.4 mill. Partners Colourbox ApS People COLOURBOX ApS Read more about the project
Globalstars, Photonics 2018 - MIRDIAL	2019 - 2021	International collaborations
Globalstars, Photonics 2018 - MIRDIAL Period 2019 - 2021 Region Program Internationale samarbejder Area Produktion, Materialer, Digitalisering og IKT Investment Percentage 28.92 Invested 2.2 mill. Budget 7.5 mill. Partners DFM, Nlir ApS, HC Photonics, Cimel Electronique People DFM Read more about the project
Globalstars, Singapore 2019 - Bralco-Grundfos	2020 - 2022	International collaborations
Globalstars, Singapore 2019 - Bralco-Grundfos Period 2020 - 2022 Region Program Internationale samarbejder Area Produktion, Materialer, Digitalisering og IKT Investment Percentage 24 Invested 1.7 mill. Budget 7.1 mill. Partners Grundfos A/S, Bralco Advanced Materials Pte Ltd People Grundfos A/S Read more about the project
Globalstars, Singapore 2019 - ShapeUV	2020 - 2022	International collaborations
Globalstars, Singapore 2019 - ShapeUV Period 2020 - 2022 Region Program Internationale samarbejder Area Produktion, Materialer, Digitalisering og IKT Investment Percentage 29.27 Invested 1.4 mill. Budget 4.6 mill. Partners NKT Photonics A/S, Hylax Technology Pte Ltd People NKT Photonics A/S Read more about the project
Globalt skaleringsprojekt for digital markedsføring 1år	2019 - 2020
Globalt skaleringsprojekt for digital markedsføring 1år Period 2019 - 2020 Region Program Area Handel, Service og Samfund Investment Percentage 100 Invested 150.000 Budget 150.000 Partners Ultrafilter Skandinavien ApS People Aktiv Read more about the project
Glucocerebrosidase inducers for treatment of Parkinson’s disease	2020 - 2022	Innobooster
Glucocerebrosidase inducers for treatment of Parkinson’s disease Period 2020 - 2022 Region Region Hovedstaden Program Innobooster Area Ikke defineret Investment Percentage 33 Invested 5.0 mill. Budget 15.0 mill. Partners Orphazyme A/S People ORPHAZYME A/S Read more about the project
Glucosafe 2 - A future after Intensive Care	2021 - 2021	Innoexplorer
Glucosafe 2 - A future after Intensive Care Period 2021 - 2021 Region Region Nordjylland Program Innoexplorer Area Biotek, Medico og Sundhed Investment Percentage 100 Invested 1.5 mill. Budget 1.5 mill. Partners Aalborg Universitet, FRB7D People Aalborg Universitet, FRB7D Read more about the project
GluLight, a continous optical glucose sensor for diabetes.GluLight combines microdialysis and refractometry: Refractive index of Water increases with increasing glucose content.	2025 - 2026	Innofounder $View project, GluLight, a continous optical glucose sensor for diabetes.GluLight combines microdialysis and refractometry: Refractive index of Water increases with increasing glucose content.$
GluLight, a continous optical glucose sensor for diabetes.GluLight combines microdialysis and refractometry: Refractive index of Water increases with increasing glucose content. Period 2025 - 2026 Region Program Innofounder Area Ikke defineret Investment Percentage 100 Invested 760.000 Budget 760.000 Hvis blodsukkeret ikke er velkontrolleret, er personer med diabetes i risiko for at udvikle senkomplikationer som retinopati (diabetisk øjensygdomr), diabetisk fod, hjerteanfald, slagtilfælde, nefropati (diabetisk nyresygdom) og neuropati (nervebetændelse). Disse tilstande påvirker livskvaliteten og forventet levetid negativt. For samfundet er senkomplikationer ved dårligt kontrolleret diabetes omkostningstunge. Ifølge CDC (Center for Disease Control) kostede dårligt kontrolleret diabetes i 2022 USA 413 milliarder USD (direkte og indirekte medicinske omkostninger samt tabte arbejdsfortjeneste). GluLight gør det meget lettere at kontrollere blodsukkeret. Denne næste generation af kontinuerlige glukosemonitorer (CGM) lover enestående nøjagtighed og brugervenlighed. I modsætning til traditionelle CGM-systemer, der bruger kemiske sensorer til at overvåge glukoseniveauer, anvender GluLight-sensoren en patenteret, banebrydende kombination af fiberoptik og mikrodialyse-teknologi. Denne revolutionerende tilgang bruger infrarødt lys, der reflekteres fra dialysatet inde i mikrodialyseproben, til præcist at måle glukoseniveauer i den interstitielle væske. Derudover har sensoren en forudsigelsesalgoritme, der informerer brugeren om den nødvendige insulintilførsel til enhver tid. Partners Glusera ApS People Glusera ApS Read more about the project
Gluten Fri brød i frisk koncept	2017 - 2018	Innobooster
Gluten Fri brød i frisk koncept Period 2017 - 2018 Region Region Midtjylland Program Innobooster Area Ikke defineret Investment Percentage 33 Invested 226.875 Budget 687.500 Partners Nordic gluten Free Bakery ApS People Nordic Gluten Free Bakery ApS Read more about the project
GLX Analytix - introducing the first blood-based composite biomarkers test for Multiple sclerosis	2020 - 2021	Innobooster
GLX Analytix - introducing the first blood-based composite biomarkers test for Multiple sclerosis Period 2020 - 2021 Region Region Hovedstaden Program Innobooster Area Ikke defineret Investment Percentage 29.12 Invested 525.260 Budget 1.8 mill. Partners GLX Analytix ApS People GLX Analytix ApS Read more about the project
GLXelerate Glycocalyx-based diagnostic accelerator for early detection and monitoring of chronic disease from a blood sample.	2025 - 2026	Grand Solutions
GLXelerate Glycocalyx-based diagnostic accelerator for early detection and monitoring of chronic disease from a blood sample. Period 2025 - 2026 Region Program Grand Solutions Area Ikke defineret Investment Percentage 73.73 Invested 11.9 mill. Budget 16.2 mill. Partners Aarhus University, Cedars Sinai Medical Center, Copenhagen University Hospital (Rigshospitalet), GLX Analytix ApS, Mass General Brigham Hospital People GLX Analytix ApS Read more about the project
Glyco-engineering of Biopharmaceuticals	2017 - 2018	Innobooster
Glyco-engineering of Biopharmaceuticals Period 2017 - 2018 Region Region Hovedstaden Program Innobooster Area Ikke defineret Investment Percentage 32.74 Invested 959.317 Budget 2.9 mill. Partners GlycoDisplay Aps People GlycoDisplay ApS Read more about the project
GLYCOSTAT Glycostat market entry supported by clinical study involving seriously ill patients	2022 - 2023	Grand Solutions
GLYCOSTAT Glycostat market entry supported by clinical study involving seriously ill patients Period 2022 - 2023 Region Region Syddanmark Program Grand Solutions Area Ikke defineret Investment Percentage 74.97 Invested 5.0 mill. Budget 6.7 mill. Partners FLOWSION A/S, Aalborg Universitetshospital People FLOWSION A/S Read more about the project
GLYON – recycled textile fibres which can reduce the carbon footprint associated with conventional fiber building block production systems by 57-59%.	2026 - 2027	Innofounder
GLYON – recycled textile fibres which can reduce the carbon footprint associated with conventional fiber building block production systems by 57-59%. Period 2026 - 2027 Region Program Innofounder Area Ikke defineret Investment Percentage 100 Invested 760.000 Budget 760.000 Our patent-pending technology can separate & recycle PET & cotton fibers. We recycle PET (Polyester)-based textiles, including blends with cotton fibers. We recycle the plastic fractions into the PET-building block, BHET, leaving us with the cotton fibres. Partners Glyon ApS People Glyon ApS Read more about the project
GLYON: CO2-catalyzed textile recycling	2025 - 2025	Innobooster
GLYON: CO2-catalyzed textile recycling Period 2025 - 2025 Region Program Innobooster Area Ikke defineret Investment Percentage 34.99 Invested 1.3 mill. Budget 3.8 mill. Partners Glyon ApS People Glyon ApS Read more about the project